The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
On the nucleation of amyloid β‐protein monomer folding
Open accessAbstract
Neurotoxic assemblies of the amyloid β‐protein (Aβ) have been linked strongly to the pathogenesis of Alzheimer's disease (AD). Here, we sought to monitor the earliest step in Aβ assembly, the creation of a folding nucleus, from which oligomeric and fibrillar assemblies emanate. To do so, limited proteolysis/mass spectrometry was used to identify protease‐resistant segments within monomeric Aβ(1–40) and Aβ(1–42). The results revealed a 10‐residue, protease‐resistant segment, Ala21–Ala30, in both peptides. Remarkably, the homologous decapeptide, Aβ(21–30), displayed identical protease resistance, making it amenable to detailed structural study using solution‐state NMR. Structure calculations revealed a turn formed by residues Val24–Lys28. Three factors contribute to the stability of the turn, the intrinsic propensities of the Val‐Gly‐Ser‐Asn and Gly‐Ser‐Asn‐Lys sequences to form a β‐turn, long‐range Coulombic interactions between Lys28 and either Glu22 or Asp23, and hydrophobic interaction between the isopropyl and butyl side chains of Val24 and Lys28, respectively. We postulate that turn formation within the Val24–Lys28 region of Aβ nucleates the intramolecular folding of Aβ monomer, and from this step, subsequent assembly proceeds. This model provides a mechanistic basis for the pathologic effects of amino acid substitutions at Glu22 and Asp23 that are linked to familial forms of AD or cerebral amyloid angiopathy. Our studies also revealed that common C‐terminal peptide segments within Aβ(1–40) and Aβ(1–42) have distinct structures, an observation of relevance for understanding the strong disease association of increased Aβ(1–42) production. Our results suggest that therapeutic approaches targeting the Val24–Lys28 turn or the Aβ(1–42)‐specific C‐terminal fold may hold promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMR with Proteins and Nucleic Acids
Wüthrich, K. (1986) · Europhysics News · doi:10.1051/epn/19861701011 · Cited by 7,989
NMR of Proteins and Nucleic Acids
(2006) · Nuclear Magnetic Resonance · doi:10.1039/9781847555236-00336 · Cited by 5,863
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy
Bax, A., & Davis, D. G. (1985) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(85)90018-6 · Cited by 3,597
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Sreerama, N., & Woody, R. W. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4880 · Cited by 2,992
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“Historically, the assembly of Ab into amyloid fibrils was thought to initiate a pathogenic cascade resulting in AD (the amyloid cascade hypothesis) (Hardy and Allsop 1991).”
BackgroundProtein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationPrimary structure effects on peptide group hydrogen exchange
Bai, Y., Milne, J. S., Mayne, L., & Englander, S. W. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340170110 · Cited by 1,902
Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., & Tycko, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262663499 · Cited by 1,845
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 1×
“Keywords: Alzheimer’s disease; amyloid; amyloid b-protein; folding nucleus; protein folding Supplemental material: see www.proteinscience.org The amyloid b-protein (Ab) is a normal, soluble component of human plasma and cerebrospinal fluid (Haass et al. 1992; Seubert et al. 1992; Shoji et al. 1992).”
BackgroundMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways
Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., & Teplow, D. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222681699 · Cited by 1,287
Self-citationThe 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209
Self-citationAmyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145
Self-citationAmyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Self-citationTargeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design.
Marqusee, S., & Baldwin, R. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8898 · Cited by 952
A revised set of potentials for β‐turn formation in proteins
Hutchinson, E. G., & Thornton, J. M. (1994) · Protein Science · doi:10.1002/pro.5560031206 · Cited by 937
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Self-citationLomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., & Teplow, D. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1125 · Cited by 787
Self-citationAllan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90255-6 · Cited by 697
Kirkitadze, M. D., Condron, M. M., & Teplow, D. B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4970 · Cited by 682
Self-citationBarrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 635
Kirkitadze, M. D., Bitan, G., & Teplow, D. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10328 · Cited by 585
Self-citationAggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P., & Craik, D. J. (1998) · Biochemistry · doi:10.1021/bi972979f · Cited by 526
Hou, L., Shao, H., Zhang, Y., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I.-J. L., Ray, D. G., Vitek, M. P., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja036813f · Cited by 525
Grabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523
Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease
Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 483
Self-citationHavel, T. F. (1991) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(91)90007-f · Cited by 422
The structural aspects of limited proteolysis of native proteins
Hubbard, S. J. (1998) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00175-1 · Cited by 406
Ma, B., & Nussinov, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212206899 · Cited by 403
Amyloid β-Protein Oligomerization
Bitan, G., Lomakin, A., & Teplow, D. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102223200 · Cited by 387
Self-citationAmyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome
Iwatsubo, T., Mann, D. M. A., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Annals of Neurology · doi:10.1002/ana.410370305 · Cited by 384
Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., & Holzman, T. F. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80591-0 · Cited by 381
Mapping Aβ Amyloid Fibril Secondary Structure Using Scanning Proline Mutagenesis
Williams, A. D., Portelius, E., Kheterpal, I., Guo, J.-T., Cook, K. D., Xu, Y., & Wetzel, R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.008 · Cited by 378
Progress towards a molecular-level structural understanding of amyloid fibrils
Tycko, R. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.12.002 · Cited by 373
Alzheimer's Disease Amyloid Propagation by a Template-Dependent Dock-Lock Mechanism
Esler, W. P., Stimson, E. R., Jennings, J. M., Vinters, H. V., Ghilardi, J. R., Lee, J. P., Mantyh, P. W., & Maggio, J. E. (2000) · Biochemistry · doi:10.1021/bi992933h · Cited by 362
Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
The Alzheimer's Peptide Aβ Adopts a Collapsed Coil Structure in Water
Zhang, S., Iwata, K., Lachenmann, M. J., Peng, J. W., Li, S., Stimson, E. R., Lu, Y.-A., Felix, A. M., Maggio, J. E., & Lee, J. P. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4288 · Cited by 336
Evidence that Aβ42 is the real culprit in alzheimer's disease
Younkin, S. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370303 · Cited by 333
In silico study of amyloid β-protein folding and oligomerization
Urbanc, B., Cruz, L., Yun, S., Buldyrev, S. V., Bitan, G., Teplow, D. B., & Stanley, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408153101 · Cited by 332
Self-citationSoto, C., Castaño, E. M., Frangione, B., & Inestrosa, N. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3063 · Cited by 321
Probing the partly folded states of proteins by limited proteolysis
Fontana, A., Polverino de Laureto, P., De Filippis, V., Scaramella, E., & Zambonin, M. (1997) · Folding and Design · doi:10.1016/s1359-0278(97)00010-2 · Cited by 309
Shao, H., Jao, S.-C., Ma, K., & Zagorski, M. G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2348 · Cited by 307
Structure of Amyloid A4‐(1–40)‐Peptide of Alzheimer's Disease
Sticht, H., Bayer, P., Willbold, D., Dames, S., Hilbich, C., Beyreuther, K., Frank, R. W., & Rösch, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.293_1.x · Cited by 300
Structural and kinetic features of amyloid β-protein fibrillogenesis: Review
Teplow, D. B. (1998) · Amyloid · doi:10.3109/13506129808995290 · Cited by 283
Self-citationTemperature dependence of amyloid β-protein fibrillization
Kusumoto, Y., Lomakin, A., Teplow, D. B., & Benedek, G. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12277 · Cited by 277
Self-citationLinkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'dahl, S., Nemens, E. J., & White, J. A. (1992) · PubMed · Cited by 270
The C‐Terminus of the β Protein is Critical in Amyloidogenesisa
JARRETT, J. T., BERGER, E. P., & LANSBURY, P. T. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23043.x · Cited by 260
Fezoui, Y., Hartley, D. M., Harper, J. D., Khurana, R., Walsh, D. M., Condron, M. M., Selkoe, D. J., Lansbury, P. T., Fink, A. L., & Teplow, D. B. (2000) · Amyloid · doi:10.3109/13506120009146831 · Cited by 260
Self-citationWisniewski, T., Ghiso, J., & Frangione, B. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91706-i · Cited by 249
Aβ40-Lactam(D23/K28) Models a Conformation Highly Favorable for Nucleation of Amyloid
Sciarretta, K. L., Gordon, D. J., Petkova, A. T., Tycko, R., & Meredith, S. C. (2005) · Biochemistry · doi:10.1021/bi0474867 · Cited by 244
Maynard, A. J., Sharman, G. J., & Searle, M. S. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9726769 · Cited by 241
Wurth, C., Guimard, N. K., & Hecht, M. H. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00399-6 · Cited by 227
NMR of macromolecules : a practical approach
Roberts, G. C. K. (1993) · Oxford University Press eBooks · Cited by 224
The Alzheimer family of diseases: Many etiologies, one pathogenesis?
Hardy, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2095 · Cited by 220
Hou, L., Kang, I., Marchant, R. E., & Zagorski, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200338200 · Cited by 218
The Toxicity of the Alzheimer's β-Amyloid Peptide Correlates with a Distinct Fiber Morphology
Seilheimer, B., Bohrmann, B., Bondolfi, L., Müller, F., Stüber, D., & Döbeli, H. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3859 · Cited by 210
Structural Features of the Aβ Amyloid Fibril Elucidated by Limited Proteolysis
Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., & Wetzel, R. (2001) · Biochemistry · doi:10.1021/bi010805z · Cited by 200
Alzheimer's Disease: Biology, Diagnosis and Therapeutics
Hier, D. B. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00025 · Cited by 198
Two-Dimensional Structure of β-Amyloid(10−35) Fibrils
Benzinger, T. L. S., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E., & Meredith, S. C. (2000) · Biochemistry · doi:10.1021/bi991527v · Cited by 189
Lee, J. P., Stimson, E. R., Ghilardi, J. R., Mantyh, P. W., Lu, Y.-A., Felix, A. M., Llanos, W., Behbin, A., Cummings, M., Van Criekinge, M., et al. (1995) · Biochemistry · doi:10.1021/bi00015a033 · Cited by 170
Griffiths-Jones, S. R., Maynard, A. J., & Searle, M. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3119 · Cited by 163
A Molecular Switch in Amyloid Assembly: Met35and Amyloid β-Protein Oligomerization
Bitan, G., Tarus, B., Vollers, S. S., Lashuel, H. A., Condron, M. M., Straub, J. E., & Teplow, D. B. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0349296 · Cited by 161
Self-citationTsubuki, S., Takai, Y., & Saido, T. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13555-6 · Cited by 158
Gorevic, P. D., Castaño, E. M., Sarma, R., & Frangione, B. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91008-4 · Cited by 157
Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers
Palmblad, M., Westlind‐Danielsson, A., & Bergquist, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112218200 · Cited by 144
Gursky, O., & Aleshkov, S. B. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00228-9 · Cited by 142
Watson, A. A., Fairlie, D. P., & Craik, D. J. (1998) · Biochemistry · doi:10.1021/bi9810757 · Cited by 142
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein
Melchor, J. P., McVoy, L., & Nostrand, W. E. V. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742209.x · Cited by 132
Aβ Protofibrils Possess a Stable Core Structure Resistant to Hydrogen Exchange
Kheterpal, I., Lashuel, H. A., Hartley, D. M., Walz, T., Lansbury, P. T., & Wetzel, R. B. (2003) · Biochemistry · doi:10.1021/bi0357816 · Cited by 122
Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico
Borreguero, J. M., Urbanc, B., Lazo, N. D., Buldyrev, S. V., Teplow, D. B., & Stanley, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502006102 · Cited by 116
Self-citationCras, P. P., van Harskamp, F., Hendriks, L., Ceuterick, C., van Duijn, C. M., STEFANKO, S. Z., Albert Hofman, D., Kros, J. M., Broeckhoven, C. V., Martin, J., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050892 · Cited by 115
Energy landscape theory for Alzheimer's amyloid ?-peptide fibril elongation
Massi, F., & Straub, J. E. (2000) · Proteins Structure Function and Bioinformatics · Cited by 110
Protein Aggregation and Amyloid Fibril Formation by an SH3 Domain Probed by Limited Proteolysis
de Laureto, P. P., Taddei, N., Frare, E., Capanni, C., Costantini, S., Zurdo, J., Chiti, F., Dobson, C. M., & Fontana, A. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.024 · Cited by 105
Protofibrils, the unifying toxic molecule of neurodegenerative disorders?
Haass, C., & Steiner, H. (2001) · Nature Neuroscience · doi:10.1038/nn0901-859 · Cited by 98
Amyloid Fibrils May Be Assembled from β-Helical Protofibrils
Lazo, N. D., & Downing, D. T. (1998) · Biochemistry · doi:10.1021/bi971016d · Cited by 98
Self-citationPäiviö, A., Jarvet, J., Gräslund, A., Lannfelt, L., & Westlind‐Danielsson, A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.028 · Cited by 77
Protein–nucleic acid interactions
Yang, W., & Duyne, G. D. V. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.01.007 · Cited by 70
Spontaneous Aggregation and Cytotoxicity of the β-Amyloid Aβ1–40: A Kinetic Model
Taylor, B. M., Sarver, R. W., Fici, G. J., Poorman, R. A., Lutzke, B. S., Molinari, A., Kawabe, T. T., Kappenman, K., Buhl, A. E., & Epps, D. E. V. (2003) · Journal of Protein Chemistry · doi:10.1023/a:1023063626770 · Cited by 48
The βA4 Amyloid Precursor Protein Gene and Alzheimer's Disease
Hendriks, L., & Broeckhoven, C. V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0006n.x · Cited by 44
The effect of vicinal polar and charged groups on hydrophobic hydration
Cheng, Y., & Rossky, P. J. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(199912)50:7<733::aid-bip6>3.0.co;2-7 · Cited by 34
Sun, X., Mo, Z., Taylor, B. M., & Epps, D. E. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.007 · Cited by 25
Conformational Mapping of Amyloid Peptides from the Putative Neurotoxic 25-35 Region
Laczkó, I., Holly, S., Kónya, Z., Soós, K., Varga, J. L., Hollósi, M., & Penke, B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2638 · Cited by 22
Cited by
Amyloid β-Protein Assembly and Alzheimer Disease
Roychaudhuri, R., Yang, M., Hoshi, M. M., & Teplow, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800036200 · Cited by 615
Self-citationAmyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N.-V., Coté, S., De Simone, A., Doig, A. J., Faller, P., Garcia, A., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 584
Sgourakis, N. G., Yan, Y., McCallum, S. A., Wang, C., & Garcia, A. E. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.093 · Cited by 457
A partially folded structure of amyloid-beta(1–40) in an aqueous environment
Vivekanandan, S., Brender, J. R., Lee, S. Y., & Ramamoorthy, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.133 · Cited by 432
Misfolded proteins in Alzheimer's disease and type II diabetes
DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15112f · Cited by 361
Metadata
- Authors
- Lazo, N. D., Grant, M. A., Condron, M. C., Rigby, A. C., & Teplow, D. B.
- Venue
- Protein Science
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 14
- Issue
- 6
- Pages
- 1581-1596
- ISSN
- 0961-8368 (ISSN-L)
- 1469-896X
- OpenAlex
- W2000659036
- Cited by
- 331
- References
- 90
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.